Crusted and eroded plaques in metastatic lung cancer
2024

Crusted and Eroded Plaques in Metastatic Lung Cancer

publication Evidence: moderate

Author Information

Author(s): Wang Robin, Zahirsha Zisansha, Zelman Brandon, Speiser Jodi, Dahiya Madhu, Eilers David

Primary Institution: Loyola University Medical Center

Hypothesis

What is the diagnosis for a patient with a painful rash receiving atezolizumab therapy?

Conclusion

The patient was diagnosed with immune checkpoint inhibitor-induced bullous pemphigoid triggered by atezolizumab.

Supporting Evidence

  • The patient initially developed bullae which subsequently led to the eroded plaques seen on physical exam.
  • Histopathology demonstrates subepidermal blistering and direct immunofluorescence shows linear C3 and IgG deposition along the basement membrane.

Takeaway

A man with lung cancer developed painful skin plaques after starting a new cancer treatment, which turned out to be a side effect of the medication.

Methodology

The case involved a patient with a history of lung cancer and treatment with atezolizumab, who presented with a rash that was examined and diagnosed based on clinical and histopathological findings.

Participant Demographics

A 72-year-old man with a history of hypertension and monoclonal gammopathy.

Digital Object Identifier (DOI)

10.1016/j.jdcr.2024.10.018

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication